Antonio R. Pera - 14 Aug 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
Director
Signature
/s/ Antonio R. Pera, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
14 Aug 2023
Net transactions value
-$181,110
Form type
4
Filing time
15 Aug 2023, 20:45:44 UTC
Previous filing
24 May 2023
Next filing
06 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $181,110 -3,000 -8.2% $60.37 33,627 14 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.12 to $60.83, inclusive.